CD94 transcripts imply a better prognosis in nasal-type extranodal NK/T-cell lymphoma

Blood

Volumn 102, Issue 7, 2003, Pages 2623-2631

  Lin, Chung Wu ^b   Chen, Yu Hua ^b   Chuang, Yi Chun ^b   Liu, Ting Yun ^b   Hsu, Su Ming ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD94 ANTIGEN; KILLER IMMUNOGLOBULIN LIKE RECEPTOR; NATURAL KILLER CELL ANTIGEN RECEPTOR; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CELL LINEAGE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KAPLAN MEIER METHOD; MALE; NATURAL KILLER CELL; NK CELL LYMPHOMA; NUCLEOTIDE SEQUENCE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL; T CELL LYMPHOMA;

EID: 0141593502     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-01-0295     Document Type: Article

References (41)

1. Jaffe ES, Harris NL, Stein H, et al. World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001.
2. Jaffe ES. Classification of natural killer (NK) cell and NK-like T-cell malignancies. Blood. 1996;87:1207-1210.
3. Kwong YL, Chan AC, Liang R, et al. CD56+ NK lymphoma: clinicopathological features and prognosis. Br J Haematol. 1997;97:821-829.
4. Sanchez MJ, Spits H, Lanier LL, et al. Human natural killer cell committed thymocytes and their relation to the T cell lineage. J Exp Med. 1993;178:1857-1866.
5. Sanchez MJ, Muench MO, Roncarolo MG, et al. Identification of a common T/natural killer cell progenitor in human fetal thymus. J Exp Med. 1994;180:569-576.
6. Suzumiya J, Takeshita M, Kimura N, et al. Expression of adult and fetal natural killer cell markers in nasal-type extranodal NK/T-cell lymphoma lymphomas. Blood. 1994;83:2255-2260.
7. Phillips JH, Horl T, Nagler A, et al. Ontogeny of human natural killer cells: fetal NK cells mediate cytolytic function and express cytoplasmic CD3ε, δ proteins. J Exp Med. 1982;175:1055-1066.
8. Lanier LL, Chang C, Spits H, et al. Expression of cytoplasmic CD3ε proteins in activated human adult NK cells and CD3γ, δ, ε complexes in fetal NK cells: implications for the relationship of NK and T lymphocytes. J Immunol. 1992;14:18761880.
9. Natarajan K, Dimasi N, Wang J, et al. Structure and function of natural killer cell receptors: multiple molecular solutions to self, nonself discrimination. Annu Rev Immunol. 2002;20:853-885.
10. Raulet DH, Vance RE, McMahon CW. Regulation of the natural killer cell receptor repertoire. Annu Rey Immunol. 2001;19:291-330.
11. Vilches C, Parham P. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Ann Rev Immunol. 2002;20:217-251.
12. Long EO, Rajagopalan S. HLAclass I recognition by killer cell Ig-like receptors. Semin Immunol. 2000;12:101-108.
13. Wilson MJ, Torkar M, Trowsdale J. Genomic organization of a human killer cell inhibitory receptor gene. Tissue Antigens. 1997;49:574-579.
14. Steffens U, Vyas Y, Dupont B, et al. Nucleotide and amino acid sequence alignment for human killer cell inhibitory receptors (KIR), 1998. Tissue Antigens. 1998;51:386-413.
15. Lin CW, Lee WH, Chang CL, et al. Restricted killer cell immunoglobulin-like receptor repertoire without T-cell receptor γ rearrangement supports a true NK-cell lineage in a subset of nasal-type extranodal NK/T-cell lymphoma lymphomas. Am J Path. 2001;159:1671-1679.
16. Lin CW, Yang JY, Chuang YC, et al. Presence of restricted killer immunoglobulin-like receptor repertoire and monoclonal T-cell receptor γ rearrangement as evidence of mixed NK/T-cell differentiation in a subset of nasal-type extranodal NK/ T-cell lymphoma lymphomas. Lab Invest. 2003;83:55-64.
17. Lopez-Botet M, Perez-Villar JJ, Carreterro M, et al. Structure and function of the CD94 C-type lectin receptor complex involved in recognition of HLA class I molecules. Immunol Rev. 1997;155:165-174.
18. Takei F, McQueen KL, Maeda M, et al. Ly49 and CD94/NKG2A: developmentally regulated expression and evolution. Immunol Rev. 2001;181:90-103.
19. Lian RH, Maeda M, Lohwasser S, et al. Orderly and nonstochastic acquisition of CD94/NKG2 receptors by developing NK cells derived from embryonic stem cells in vitro. J Immunol. 2002;168:4980-4987.
20. Williams NS, Kubota A, Bennett M, et al. Clonal analysis of NK cell development from bone marrow progenitors in vitro: orderly acquisition of receptor gene expression. Eur J Immunol. 2000;30:2074-2082.
21. Kubota A, Kubota S, Lohwasswe S, et al. Diversity of NK cell receptor repertoire in adult and neonatal mice. J Immunol. 1999;163:212-216.
22. Perez-Villar JJ, Carretero M, Navarro F, et al. Biological and serological evidence for the existence of functionally distinct forms of CD94 NK cell receptors. J Immunol. 1996;157:5367-5374.
23. Mori KL, Egashira M, Oshimi K. Differentiation stage of natural killer cell-lineage lymphoproliferative disorders based on phenotypic analysis. Br J Haematol. 2001;115:225-228.
24. Lin CW, Chang CL, Li CC, et al. Spontaneous regression of Kikuchi's lymphadenopathy with oligoclonal T-cell populations favors a benign immune reaction over a T-cell lymphoma. Am J Clin Path. 2002;117:627-635.
25. Chang C, Rodriguez A, Carretero M, et al. Molecular characterization of human CD94: a type II membrane glycoprotein related to the C-type lectin superfamily. Eur J Immunol. 1995;25:2433-2437.
26. Rodriguez A, Carretero M, Glienke J, et al. Structure of the human CD94 C-type lectin gene. Immunogenetics. 1998;47:305-309.
27. Houchins JP, Yabe T, McSherry C, et al. DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins in human natural killer cells. J Exp Med. 1991;173:1017-1020.
28. Plougastel B, Jones T, Trowsdale J. Genomic structure, chromosome location, and alternative splicing of the human NKG2A gene. Immunogenetics. 1996;44:286-291.
29. Adamkiewicz TV, McSherry C, Bach FH, et al. Natural killer lectin-like receptors have divergent carboxy-termini, distinct from C-type lectins. Immunogenetics. 1994;39:218-218.
30. Glienke J, Sobanov Y, Brostjan C, et al. The genomic organization of NKG2C, E, F, and D receptors in the human natural killer gene complex. Immunogenetics. 1998;48:163-173.
31. Steward M, Bishpo R, Piggott NH, et al. Production and characterization of a new monoclonal antibody effective in recognizing the CD3 T-cell associated antigen in formalin-fixed embedded tissue. Histopathology. 1997;30:16-22.
32. Haedicke W, Ho FC, Chott A, et al. Expression of CD94/NKG2A and killer immunoglobulin-like receptors in NK cells and a subset of extranodal cytotoxic T-cell lymphomas. Blood. 2000;95:3628-3630.
33. Hoffman T, de Libero G, Colonna M, et al. Natural killer-type receptors for HLA class I antigens are clonally expressed in lymphoproliferative disorders of natural killer cell and T-cell type. Br J Haematol. 2000;110:525-536.
34. Dukers DF, Vermeer MH, Jaspars LH, et al. Expression of killer cell inhibitory receptors is restricted to true NK cell lymphomas and a subset of intestinal enteropathy-type T cell lymphomas with a cytotoxic phenotype. J Clinical Path. 2001;54:224-228.
35. Morice WG, Kurtin PJ, Leibson PJ, et al. Demonstration of aberrant T-cell and natural killer-cell antigen expression in all cases of granular lymphocytic leukaemia. Br J Haematol. 2003;120:1026-1036.
36. Nakamura F, Tatsumi E, Kawano S, et al. Acute lymphoblastic leukemia/lymphoblastic lymphoma of natural killer (NK) lineage: quest for another NK-lineage neoplasm. Blood. 1997;89:4665-4666.
37. Miller JS, McCullar V. Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2. Blood. 2001;98:705-713.
38. Szczepanski T, Pongers-Willemse MJ, Langerak AW, et al. Ig heavy chain gene rearrangements in T-cell acute lymphoblastic leukemia exhibit predominant DH6-19 and DH7-27 gene usage, can result in complete V-D-J rearrangements, and are rare in T-cell receptor alpha beta lineage. Blood. 1999;93:4079-4085.
39. van Oers NSC. T cell receptor-mediated signs and signals governing T cell development. Semin Immunol. 1999;11:227-237.
40. Niro H, Clark EA. Regulation of B-cell fate by antigen-receptor signals. Nat Rev Immunol. 2002;2:945-956.
41. Stepp SE, Dufourcq-Lagelouse R, Le Deist F, et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science. 1999;286:1957-1959.